Market closed
Hologic/$HOLX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Hologic
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Ticker
$HOLX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
7,063
Website
Hologic Metrics
BasicAdvanced
$16B
Market cap
21.58
P/E ratio
$3.32
EPS
0.96
Beta
-
Dividend rate
Price and volume
Market cap
$16B
Beta
0.96
52-week high
$84.67
52-week low
$70.36
Average daily volume
2.2M
Financial strength
Current ratio
3.686
Quick ratio
2.832
Long term debt to equity
50.554
Total debt to equity
51.817
Interest coverage (TTM)
7.95%
Management effectiveness
Return on assets (TTM)
6.63%
Return on equity (TTM)
15.56%
Valuation
Price to earnings (TTM)
21.581
Price to revenue (TTM)
4.191
Price to book
3.24
Price to tangible book (TTM)
19.71
Price to free cash flow (TTM)
14.751
Growth
Revenue change (TTM)
-0.00%
Earnings per share change (TTM)
81.42%
3-year revenue growth (CAGR)
-10.56%
3-year earnings per share growth (CAGR)
-22.78%
What the Analysts think about Hologic
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Hologic stock.
Hologic Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Hologic Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Hologic News
AllArticlesVideos
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC
Business Wire·6 days ago
Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines
Business Wire·2 weeks ago
Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Hologic stock?
Hologic (HOLX) has a market cap of $16B as of December 24, 2024.
What is the P/E ratio for Hologic stock?
The price to earnings (P/E) ratio for Hologic (HOLX) stock is 21.58 as of December 24, 2024.
Does Hologic stock pay dividends?
No, Hologic (HOLX) stock does not pay dividends to its shareholders as of December 24, 2024.
When is the next Hologic dividend payment date?
Hologic (HOLX) stock does not pay dividends to its shareholders.
What is the beta indicator for Hologic?
Hologic (HOLX) has a beta rating of 0.96. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.